Le renouveau des antagonistes de l'atdostérone [The revived interest in aldosterone antagonists]
Data(s) |
2006
|
---|---|
Resumo |
Aldosterone plays a pivotal role in sodium and water homeostasis, in particular in patients with heart failure or high blood pressure. These medications, when used on top of a standard therapy, improve the outcome of patients with heart failure and are also effective in lowering blood pressure of hypertensive patients. The major risk associated with the use of these antagonists is hyperkalemia, which can be prevented in avoiding their prescription in patients with impaired renal function. Eplerenone has the advantage, compared with spironolactone, to be better tolerated in terms of "hormonal" adverse effects. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_F2AC51DDF1E7 isbn:1660-9379 pmid:17019841 |
Idioma(s) |
fr |
Fonte |
Revue Médicale Suisse, vol. 2, no. 78, pp. 2055-2058 |
Palavras-Chave | #Aldosterone Antagonists; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Hypokalemia; Spironolactone; Treatment Outcome |
Tipo |
info:eu-repo/semantics/review article |